Replicate Bioscience Revenue and Competitors

Location

$46M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Replicate Bioscience's estimated annual revenue is currently $1.9M per year.(i)
  • Replicate Bioscience's estimated revenue per employee is $77,500
  • Replicate Bioscience's total funding is $46M.

Employee Data

  • Replicate Bioscience has 24 Employees.(i)
  • Replicate Bioscience grew their employee count by 0% last year.

Replicate Bioscience's People

NameTitleEmail/Phone
1
CEO and Co-FounderReveal Email/Phone
2
Head Research & DevelopmentReveal Email/Phone
3
Chief Business OfficerReveal Email/Phone
4
Scientific Director | Head TechnologyReveal Email/Phone
5
Director PharmacologyReveal Email/Phone
6
Co-founder and Chief Development OfficerReveal Email/Phone
7
Chief Medical OfficerReveal Email/Phone
8
Senior Program ManagerReveal Email/Phone
9
Senior ScientistReveal Email/Phone
10
Principal ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Replicate Bioscience?

Replicate harnesses the body’s natural protein-making power and uses synthetic biology to design unique self-replicating RNAs (srRNAs) that can direct that power to fight disease. With our customizable srRNA platform and our diverse repertoire of virally derived vectors, we are tackling drug resistance in cancers and discovering new treatments for autoimmune and inflammatory disorders and other diseases. Replicate is working to make srRNA therapeutics broadly accessible, to realize their promise for all patients.

keywords:N/A

$46M

Total Funding

24

Number of Employees

$1.9M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$182.7M244%N/A
#2
$2.4M24N/AN/A
#3
$2.4M24N/AN/A
#4
$3.9M24-8%$1.2M
#5
$5.6M24-11%N/A